✦ LIBER ✦

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 10-week open-label study

✍ Scribed by Mehmet Ak; Suheyla Dogan Bulut; Ali Bozkurt; Aytekin Ozsahin

Book ID: 107648742
Publisher: Springer Healthcare Communications
Year: 2011
Tongue: English
Weight: 515 KB
Volume: 28
Category: Article
ISSN: 0741-238X
DOI: 10.1007/s12325-011-0011-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topiramate augmentation in treatment-res

Topiramate augmentation in treatment-resistant obsessive–compulsive disorder: a retrospective, open-label case series

✍ Michael Van Ameringen; Catherine Mancini; Beth Patterson; Mark Bennett 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 1 views

The comparison of aripiprazole and rispe

The comparison of aripiprazole and risperidone augmentation in selective serotonin reuptake inhibitor-refractory obsessive-compulsive disorder: a single-blind, randomised study

✍ Yavuz Selvi; Abdullah Atli; Adem Aydin; Lutfullah Besiroglu; Pinar Ozdemir; Osma 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 339 KB

## Abstract ## Objective To investigate the comparative efficacy of aripiprazole and risperidone as augmenting agents in the treatment of obsessive‐compulsive disorder (OCD) patients who did not show a ≥35% decrease in the Yale‐Brown Obsessive‐Compulsive Scale (Y‐BOCS) after 12‐week monotherapy wi

Open-label pilot study of tramadol hydro

Open-label pilot study of tramadol hydrochloride in treatment-refractory obsessive-compulsive disorder

✍ Nathan A. Shapira; Paul E. Keck Jr.; Toby D. Goldsmith; Brian J. McConville; Mic 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB 👁 2 views